BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18567798)

  • 1. Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.
    Lu XY; Lu Y; Zhao YJ; Jaeweon K; Kang J; Xiao-Nan L; Ge G; Meyer R; Perlaky L; Hicks J; Chintagumpala M; Cai WW; Ladanyi M; Gorlick R; Lau CC; Pati D; Sheldon M; Rao PH
    Mol Cancer Res; 2008 Jun; 6(6):937-46. PubMed ID: 18567798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
    Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
    BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma.
    Lau CC; Harris CP; Lu XY; Perlaky L; Gogineni S; Chintagumpala M; Hicks J; Johnson ME; Davino NA; Huvos AG; Meyers PA; Healy JH; Gorlick R; Rao PH
    Genes Chromosomes Cancer; 2004 Jan; 39(1):11-21. PubMed ID: 14603437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
    Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
    Ma O; Cai WW; Zender L; Dayaram T; Shen J; Herron AJ; Lowe SW; Man TK; Lau CC; Donehower LA
    Cancer Res; 2009 Mar; 69(6):2559-67. PubMed ID: 19276372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX2 (6p21.1) amplification in osteosarcoma.
    Gupta S; Ito T; Alex D; Vanderbilt CM; Chang JC; Islamdoust N; Zhang Y; Nafa K; Healey J; Ladanyi M; Hameed MR
    Hum Pathol; 2019 Dec; 94():23-28. PubMed ID: 31669178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
    van Dartel M; Redeker S; Bras J; Kool M; Hulsebos TJ
    Cancer Genet Cytogenet; 2004 Jul; 152(1):8-14. PubMed ID: 15193436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.
    Both J; Wu T; Bras J; Schaap GR; Baas F; Hulsebos TJ
    PLoS One; 2012; 7(1):e30907. PubMed ID: 22292074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioinformatics-based identification of key genes CDC5L and related pathways in osteosarcoma and Ewing's sarcoma].
    Feng N; Song WX; Shao LP; Gao YH; Zhao CW
    Zhongguo Gu Shang; 2022 Mar; 35(3):276-80. PubMed ID: 35322620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
    Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplifications in osteosarcoma-CGH microarray analysis.
    Atiye J; Wolf M; Kaur S; Monni O; Böhling T; Kivioja A; Tas E; Serra M; Tarkkanen M; Knuutila S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):158-63. PubMed ID: 15540165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement of the human CDC5L gene by a t(6;19)(p21;q13.1) in a patient with multicystic renal dysplasia.
    Groenen PM; Vanderlinden G; Devriendt K; Fryns JP; Van de Ven WJ
    Genomics; 1998 Apr; 49(2):218-29. PubMed ID: 9598309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
    Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
    J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.
    Martin JW; Chilton-MacNeill S; Koti M; van Wijnen AJ; Squire JA; Zielenska M
    PLoS One; 2014; 9(5):e95843. PubMed ID: 24835790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.
    van Dartel M; Cornelissen PW; Redeker S; Tarkkanen M; Knuutila S; Hogendoorn PC; Westerveld A; Gomes I; Bras J; Hulsebos TJ
    Cancer Genet Cytogenet; 2002 Dec; 139(2):91-6. PubMed ID: 12550767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma.
    Lim G; Karaskova J; Beheshti B; Vukovic B; Bayani J; Selvarajah S; Watson SK; Lam WL; Zielenska M; Squire JA
    Genes Chromosomes Cancer; 2005 Apr; 42(4):392-403. PubMed ID: 15660435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridization of low-grade central osteosarcoma.
    Tarkkanen M; Böhling T; Gamberi G; Ragazzini P; Benassi MS; Kivioja A; Kallio P; Elomaa I; Picci P; Knuutila S
    Mod Pathol; 1998 May; 11(5):421-6. PubMed ID: 9619593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.